DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $19,512,000 | +11.3% | 3,752,390 | 0.0% | 0.19% | +20.1% |
Q3 2016 | $17,524,000 | +18.5% | 3,752,390 | 0.0% | 0.16% | +2.6% |
Q2 2016 | $14,784,000 | +27.1% | 3,752,390 | 0.0% | 0.16% | +26.0% |
Q1 2016 | $11,632,000 | -32.2% | 3,752,390 | 0.0% | 0.12% | -13.4% |
Q4 2015 | $17,148,000 | +5.3% | 3,752,390 | +8.5% | 0.14% | -5.3% |
Q3 2015 | $16,286,000 | -34.2% | 3,457,841 | 0.0% | 0.15% | -30.9% |
Q2 2015 | $24,758,000 | -15.5% | 3,457,841 | 0.0% | 0.22% | -11.1% |
Q1 2015 | $29,288,000 | -11.1% | 3,457,841 | -2.2% | 0.24% | -27.4% |
Q4 2014 | $32,931,000 | +11.8% | 3,537,137 | 0.0% | 0.34% | -9.4% |
Q3 2014 | $29,464,000 | -27.9% | 3,537,137 | 0.0% | 0.37% | -25.9% |
Q2 2014 | $40,889,000 | -8.8% | 3,537,137 | 0.0% | 0.50% | -12.1% |
Q1 2014 | $44,851,000 | +62.0% | 3,537,137 | +38.2% | 0.57% | +46.2% |
Q4 2013 | $27,687,000 | -12.6% | 2,558,857 | 0.0% | 0.39% | -13.3% |
Q3 2013 | $31,679,000 | +74.6% | 2,558,857 | +88.3% | 0.45% | +25.3% |
Q2 2013 | $18,141,000 | – | 1,358,857 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |